TheFly.com
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
CLNN
Clene
$
()
CLNN
Clene awarded grant from NMSS to advance development of CNM-Au8
CLNN
5/25/2023 - 08:04am
Clene price target lowered to $4 from $5 at Cantor Fitzgerald
CLNN
5/16/2023 - 07:27am
Clene reports Q1 EPS (15c), consensus (14c)
CLNN
5/12/2023 - 16:02pm
Clene price target lowered to $7 from $11 at Benchmark
CLNN
4/10/2023 - 07:28am
Clene appoints Benjamin Greenberg as head of medical
CLNN
3/16/2023 - 09:50am
Clene expects cash to fund operations into 3Q23
CLNN
3/13/2023 - 07:10am
Clene reports 2022 EPS (46c), consensus (58c)
CLNN
3/13/2023 - 07:09am
Clene price target raised to $8 from $6 at Cantor Fitzgerald
CLNN
3/10/2023 - 07:19am
Clene's CNM-Au8 associated with delay in clinical worsening for ALS patients
CLNN
3/9/2023 - 06:41am
Clene initiated with a Buy at EF Hutton
CLNN
3/8/2023 - 07:28am
Clene announces recent data from its Phase 2 RESCUE ALS trial
CLNN
3/6/2023 - 07:10am
Clene presents updated VISIONARY-MS Phase 2 trial data
CLNN
2/27/2023 - 07:25am
Clene reports new data from VISIONARY-MS Phase 2 study
CLNN
2/13/2023 - 07:09am
Benchmark maintains Buy rating, $11 target on Clene after COVID trial miss
CLNN
12/29/2022 - 07:23am
H.C. Wainwright keeps $15 target on Clene after Phase 2 COVID miss
CLNN
12/28/2022 - 06:21am
dynamic_feed
Breaking News
search
Search
menu
Menu
TheFly.com TheFly.com
